Evaluation and management of syphilis in the HIV-infected patient

Current Infectious Disease Reports

Volumn 12, Issue 2, 2010, Pages 140-146

  Ghanem, Khalil G ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Antiretroviral therapy; HAART; HIV; Neurosyphilis; Syphilis

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; DOXYCYCLINE; MACROLIDE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONDOM; DATA ANALYSIS; DISEASE COURSE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; INFECTION RISK; NEUROSYPHILIS; OUTCOME ASSESSMENT; REVIEW; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUALITY; SYPHILIS; TREATMENT FAILURE;

EID: 77953537673     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0083-6     Document Type: Review

References (37)

1. Centers for Disease Control and Prevention: Sexually Transmitted Disease Surveillance, 2007. Atlanta, GA: US Department of Health and Human Services; 2008.
2. Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999, 75:3-17.
3. Buchacz K, Patel P, Taylor M, et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004, 18:2075-2079.
4. Dowell D, Polgreen PM, Beekmann SE, et al.: Dilemmas in the management of syphilis: A survey of infectious diseases experts. Clin Infect Dis 2009, 49:1526-1529. This study highlights the heterogeneous approach to the management of syphilis among infectious diseases providers around the country.
5. Sparling PF, Swartz MN, Musher DM, Healy BP: Clinical manifestations of syphilis. In Sexually Transmitted Diseases, edn 4. Edited by Holmes KK, Sparling PF, Stamm WE, et al. New York: McGraw-Hill; 2008:661-684.
6. Rompalo AM, Joesoef MR, O'Donnell JA, et al.: Clinical manifestations of early syphilis by HIV status and gender: Results of the syphilis and HIV study. Sex Transm Dis 2001, 28:158-165.
7. Flood JM, Weinstock HS, Guroy ME, et al.: Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis 1998, 177:931-940.
8. Centers for Disease Control and Prevention (CDC): Symptomatic early neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007, 56:625-628.
9. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA: Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008, 22:1145-1151. This study demonstrates that HAART decreased the odds of developing neurosyphilis by 65%.
10. Musher DM: Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 1991, 163:1201-1206.
11. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995, 8:1-21.
12. Centers for Disease Control and Prevention (CDC): Syphilis testing algorithms using treponemal tests for initial screening-four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008, 57:872-875. This study highlights an important trend in syphilis diagnostics: The use by some laboratories of treponemal-specific tests as the initial screening test for syphilis and the ensuing issues with the interpretation of tests.
13. Marra CM, Gary DW, Kuypers J, Jacobson MA: Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J Infect Dis 1996, 174:219-221.
14. Jaffe HW, Larsen SA, Peters M, et al.: Tests for treponemal antibody in CSF. Arch Intern Med 1978, 138:252-255.
15. Appleman ME, Marshall DW, Brey RL, et al.: Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis 1988, 158:193-199.
16. Marra CM, Maxwell CL, Collier AC, et al.: Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007, 7:37. This article provides an excellent overview of the issue of CSF abnormalities in HIV-infected patients and describes attempts at trying to improve the specificity of neurosyphilis diagnosis.
17. Marra CM: Deja vu all over again: When to perform a lumbar puncture in HIV-infected patients with syphilis. Sex Transm Dis 2007, 34:145-146.
18. Centers for Disease Control and Prevention, Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55:1-94. This article provides the definitive management guidelines for syphilis. An updated version should be available in 2010.
19. Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis 2004, 189:369-376.
20. Libois A, De Wit S, Poll B, et al.: HIV and syphilis: When to perform a lumbar puncture. Sex Transm Dis 2007, 34:141-144.
21. Ghanem KG,Moore RD, Rompalo AM, et al.: Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009, 48:816-821. This study showed that the CD4/ RPR-based criteria are superior to the stage-based criteria when attempting to detect asymptomatic neurosyphilis.
22. Berry CD, HootonTM, Collier AC, Lukehart SA: Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987, 316:1587-1589.
23. Telzak EE, Greenberg MS, Harrison J, et al.: Syphilis treatment response in HIV-infected individuals. AIDS 1991, 5:591-595.
24. Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997, 337:307-314.
25. Ghanem KG, Erbelding EJ, ChengWW, Rompalo AM: Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis 2006, 42:e45-e49.
26. Riedner G, Rusizoka M, Todd J, et al.: Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005, 353:1236-1244.
27. Lukehart SA, Godornes C, Molini BJ, et al.: Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004, 351:154-158.
28. Hook EW 3rd, Roddy RE, Handsfield HH: Ceftriaxone therapy for incubating and early syphilis. J Infect Dis 1988, 158:881-884.
29. Smith NH, Musher DM, Huang DB, et al.: Response of HIVinfected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15:328-332.
30. Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter? Clin Infect Dis 2004, 38:1001-1006.
31. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM: Serological response to syphilis treatment in HIV-positive and HIV negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007, 83:97-101.
32. Gonzalez-Lopez JJ, Guerrero ML, Lujan R, et al.: Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis 2009, 49:1505-1511.
33. Marra CM,Maxwell CL, Tantalo LC, et al.:Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008, 47:893-899. This recent study suggests that normalization of the serum RPR often predicts normalization of CSF parameters in HIV-infected patients with neurosyphilis who are on HAART.
34. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA: Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008, 47:258-265. This study demonstrated improved serological outcomes in HIV-infected patients who are treated for syphilis and who are on HAART.
35. Richardson JL, Milam J, McCutchan A, et al.: Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS 2004, 18:1179-1186.
36. Mofenson LM, Brady MT, Danner SP, et al.: Guidelines for the prevention and treatment of opportunistic infections among HIVexposed and HIV-infected children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009, 58:1-166.
37. Centers for Disease Control and Prevention (CDC): Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep 2008, 57:1,83.